Revere Pharmaceuticals is a Boston-based startup leading the way in the development of new cancer treatments targeting Rho GTPases, which play a key role in the progression of many cancers. Our lead Rac1 inhibitor is orally bioavailable and demonstrates good in vivo anti-tumor activity as a single agent in multiple tumor models.
Revere has developed a suite of proprietary biochemical and cell-based assays to evaluate our small molecule inhibitors, which are optimized using structure-based drug design. Our Rho GTPase platform has enabled Revere to build a pipeline of differentiated Rho GTPase inhibitors for different cancers.
Company Details
- Employees
- 3
- Founded
- -
- Phone
- 781-718-9033
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- reverepharma.com
- Keywords
- Oncology and Drug Development.
Revere Pharmaceuticals Questions
Revere Pharmaceuticals's helpline number is 781-718-9033
Revere Pharmaceuticals's website is reverepharma.com
Revere Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/revere-pharma
Revere Pharmaceuticals has
3 employees.
View email and phone details for 3
employees at Revere Pharmaceuticals.
Revere Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Revere Pharmaceuticals's top competitors are
Blue Hills Therapeutics Inc.,
Neurointernational,
Futurewalks Inc.,
Syner-G Biopharma Group,
Skyhawk Therapeutics,
Trudence Llc,
Rxzone,
Regenacy Pharmaceuticals, Inc.,
Beam Therapeutics,
Rational Hemp.
Revere Pharmaceuticals's support email address is info@reverepharma.com
Revere Pharmaceuticals's categories are Pharmaceutical Manufacturing
Revere Pharmaceuticals's founding year is 2016
